Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Interested In Part D Plan Collaboration With Medicare ACOs

This article was originally published in The Pink Sheet Daily

Executive Summary

In a draft version of its annual instructions to Part D plans, CMS says it is seeking feedback from Part D sponsors and other stakeholders on “possible strategies for achieving better coordination” between stand-alone Medicare Part D plans and accountable care organizations to improve pharmacy care.

You may also be interested in...



CVS Caremark Part D Plans Collaborating With Medicare ACOs On Drug Adherence

The collaboration could be an important step toward more firmly establishing the value of drug treatment in lowering overall medical spending, a key goal for biopharma manufacturers looking for ways to adapt to new patient care models.

Amid Uncertainties, Acorda Preps For Next Phase Of ACA: An Interview With Managed Markets Head Kent Rogers

With nine months to go before key aspects of the Affordable Care Act are implemented, Acorda Therapeutics’ head of managed markets, Kent Rogers, says he, like everyone, is ‘learning.” Acorda expects to have a game plan ready by mid-summer on how it will adapt its commercial strategy to ACA-initiated changes. Rogers also points out that the company may be less affected than others in the near term because Medicare already covers the majority of patients who take its multiple sclerosis drug Ampyra.

Pharmacists, HIT Can Be Key To Successful Rx Care In ACO Model

The Marshfield Clinic in Wisconsin shows how pharmacists and health information technology can be incorporated into an accountable care organization’s pharmaceutical care in a way that can help improve patient outcomes and influence prescribing behavior.

Related Content

Topics

UsernamePublicRestriction

Register

PS073799

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel